Increased eotaxin-mRNA expression in non-atopic and atopic nasal polyps: Comparison to RANTES and MCP-3 expression

Rhinology

Volumn 35, Issue 4, 1997, Pages 171-174

  Bartels, Joachim ^a   Maune, Steffen ^a   Meyer, Jens E ^a   Kulke, R ^a   Schlüter, Carsten ^a   Rowert J ^a   Christophers, Enno ^a   Schröder, Jens M ^a  

^a UNIVERSITY OF KIEL   (Germany)

Author keywords

Allergic rhinitis; Chemokines; Chemotaxins; Chronic polypous sinusitis; Eotaxin

Indexed keywords

CHEMOKINE; EOTAXIN; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 3; RANTES;

ADULT; ALLERGIC RHINITIS; ARTICLE; CHRONIC SINUSITIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MALE; NEUTROPHIL CHEMOTAXIS; NOSE MUCOSA; NOSE POLYP; NOSE SURGERY; PROTEIN EXPRESSION;

ADULT; CHEMOKINES, CC; CHEMOTACTIC FACTORS, EOSINOPHIL; CYTOKINES; FEMALE; HUMANS; HYPERSENSITIVITY, IMMEDIATE; MALE; MONOCYTE CHEMOATTRACTANT PROTEINS; NASAL POLYPS; POLYMERASE CHAIN REACTION; RANTES; RNA, MESSENGER;

EID: 0031407184     PISSN: 03000729     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Aschoff JM, Lazarus D, Fanburg BL, Lanzillo JJ (1994) Relative quantification of angiotensin-converting enzyme mRNA in human smooth muscle cells, monocytes, and lymphocytes by the polymerase chain reaction. Anal Biochem 219: 218-223.
2. Bachert C, Prem B, Dater I (1994) Zytokine in der Polyposisforschung. Eine neue Dimension. Allergologie 17: 578-582.
3. Baggiolini M, Dahinden CA (1994) CC-chemokines in allergic inflammation. Immunol Today 15: 127-133.
4. Bartels J, Schlüter C, Richter E, Noso N, Kulke R, Christophers E, Schröder JM (1996) Human dermal fibroblasts express eotaxin: Molecular cloning, mRNA expression, and identification of eotaxin sequence variants. Biochem Biophys Res Commun 225: 1045-1051.
5. Beck LA, Stellato C, Beall LD, Schall TJ, Leopold D, Bickel CA, Baroody F, Bochner BS, Schleimer RP (1996) Detection of the chemokine RANTES and endothelial adhesion molecules in nasal polyps. J Allergy Clin Immunol 98: 766-780.
6. Burke-Gaffney A, Hellewell PG (1996) Eotaxin stimulates eosinophil adhesion to human lung microvascular endothelial cells. Biochem Biophys Res Commun 227: 35-40.
7. Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159.
8. Clark Lewis I, Kim KS, Rajarathnam K, Gong JH, Dewald B, Moser B, Baggiolini M, Sykes BD (1995) Structure-activity relationships of chemokines. J Leukocyte Biol 57: 703.
9. Dahinden CA, Geiser T, Brunner T, Von Tschamer V, Caput D, Ferrara P, Minty A, Baggiolini M (1994) Monocyte chemotactic protein-3 is a most effective basophil- and eosinophil-activating chemokine. J Exp Med 179: 751-756.
10. Ebisawa M, Yamada T, Bickel C, Klunk D, Schleimer RP (1994) Eosinophil transendothelial migration induced by cytokines. III. Effect of the chemokine RANTES. J Immunol 153: 2153-2160.
11. Ford SA, Baroody FM, Naclerio RM (1992) The impact of immunotherapy on the pathophysiology of ragweed pollen allergy. Rhinology Suppl 14: 52-56.
12. Garcia-Zepeda EA, Rothenberg ME, Ownbey RT, Celestin J, Leder P, Luster AD (1996) Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia. Nature Med 2: 449-456.
13. Gleich GJ (1990) The eosinophil and bronchial asthma: Current understanding. J Allergy Clin Imunol 85: 422-436.
14. Hom BR, Robin ED, Theodore J, VanKessel A (1975) Total eosinophil counts in the management of bronchial asthma N Engl J Med 292: 1152-1155.
15. Humbert M, Ying S, Corrigan C, Menz G, Barkans J, Pfister R, Meng Q, Van Damme J, Opdenakker G, Durham SR, Kay AB (1997) Bronchial mucosal expression of the genes encoding chemokines RANTES and MCP-3 in symptomatic atopic and nonatopic asthmatics: Relationship to the eosinophil-active cytokines interleukin (IL)-5, granulocyte macrophage-colony-stimulating factor, and IL-3. Am J Respir Cell Mol Biol 16: 1-8.
16. Jankowski R, Bene MC, Moneret Vautrin AD, Haas F, Faure G, Simon C, Wayoff M (1989) Immunohistological characteristics of nasal polyps. A comparison with healthy mucosa and chronic sinusitis. Rhinology Suppl 8: 51-58.
17. Kapp A (1993) The role of eosinophils in the pathogenesis of atopic dermatitis. Eosinophil granule proteins as markers of disease activity. Allergy 48: 1-5.
18. Kay AB, Barata L, Meng Q, Durham SR, Ying S (1997) Eosinophils and eosinophil-associated cytokines in allergic inflammation. Int Arch Allergy Immunol 113: 196-199.
19. Leprini A, Garaventa G, Pallestrini E, Leprini AE, Pallestrini EA (1995) Nasal polyps: Comparative immunological study of polyps with different histopathological types. Acta Otorhinolaryngol Ital 15: 323-334.
20. Linder A, Karlsson Parra A, Hirvela C, Jonsson L, Koling A, Sjoberg O (1993) Immunocompetent cells in human nasal polyps and normal mucosa. Rhinology 31: 125-129.
21. Maune S, Berner I, Sticherling M, Kulke R, Bartels J, Schröder J-M (1996a) Fibroblasts but not epithelial cells obtained from human nasal mucosa produce the chemokine RANTES. Rhinology 34: 210-214.
22. Maune S, Meyer JE, Sticherling M, Fölster-Holst R, Schröder J-M (1996b) Eosinophilen chemotaktische Aktivität in der Chemokinfraktion von Nasenpolypen. Allergologie 19: 230-233.
23. McLean A (1994) Regulation with RANTES. Lancet 343: 189-190.
24. Meurer R, Van Riper G, Feeney W, Cunningham P, Hora D, Jr., Springer MS, Macintyre DE, Rosen H (1993) Formation of eosinophilic and monocytic intradermal inflammatory sites in the dog by injection of human RANTES but not human monocyte chemoattractant protein-1, human macrophage inflammatory protein-1α, or human interleukin-8. J Exp Med 178: 1913-1921.
25. Moneret Vautrin DA, Jankowski R, Bene MC, Kanny G, Hsieh V, Faure G, Wayoff M (1992) NARES: A model of inflammation caused by activated eosinophils? Rhinology 30: 161-168.
26. Moshizuki M, Bartels J, Mallet AI, Christophers E, Schröder J-M (1997) Interleukin-4 selectively induces eotaxin in dermal fibroblasts: A possible mechanism of eosinophil recruitment in parasite defense, allergic and atopic skin disease. J. Immunol (in press).
27. Ponath PD, Qin SX, Ringler DJ, Clark-Lewis I, Wang J, Kassam N, Smith H, Shi XJ, Gonzalo JA, Newman W, Guticrrez-Ramos JC, Mackay CR (1996) Cloning of the human eosinophil chemoattractant, eotaxin. Expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils. J Clin Invest 97: 604-612.
28. Schrum S, Probst P, Fleischer B, Zipfel PF (1996) Synthesis of the CC-chemokines MIP 1a, MIP-1b, and RANTES is associated with a type-I immune response. J Immunology 157: 3598-3604.
29. Stoop AE, Van der Heijden HA, Biewenga J, Van der Baan S (1993) Eosinophils in nasal polyps and nasal mucosa: An immunohistochemical study. J Allergy Clin Immunol 91: 616-622.
30. Terada N, Konno A, Shirotori K, Togawa K (1992) In human nasal mucosa, interleukin-5 accumulates and degranulates eosinophils, as well as increases responsiveness to histamine. Rhinology Suppl 14: 57-61.
31. Teran LM, Davies DE (1996) The chemokines: Their potential role in allergic inflammation. Clin Exp Allergy 26: 1005-1019.
32. Weber M, Uguccioni M, Ochensberger B, Baggiolini M, Clark-Lewis I, Dahinden CA (1995) Monocyte chemotactic protein MCP-2 activates human basophil and eosinophil leukocytes similar to MCP-3. J Immunol 154: 4166-4172.
33. Ying S, Taborda-Barata L, Meng Q, Humbert M, Kay AB (1995) The kinetics of allergen-induced transcription of messenger RNA for monocyte chemotactic protein-3 and RANTES in the skin of human atopic subjects: Relationship to eosinophil, T cell, and macrophage recruitment. J Exp Med 181: 2153-2160.